Four British TP52s on the Audi MedCup 2011?


James Boyd Photography / www.thedailysail.com
We caught up with Johnny Vincent and Tony Longley, owners respectively of Pace and Weapon of Choice at the TP52 Worlds
While TeamOrigin may be out of the Audi MedCup next year, 2011 could see as many as four British boats racing. In addition to John Cook’s Cristabella, London-based Swede Niklas Zennstrom, who’s Tim Powell-run team is largely from the UK, recently announced their participation next year in a brand new Judel-Vrolijk designed, Green Marine-built Ràn TP52. But at the TP52 World Championship in Valencia recently there were two additional entries both of whom look set, at the very least, to dip into the Audi MedCup during 2011. Interestingly the individuals behind both campaigns are successful businessmen, who have come to competitive sailing relatively recently. Both are also keen owner-drivers. Tony Langley is Chairman and CEO of Nottinghamshire-based Langley Holdings plc, an engineering group that in 2008 employed 2500 people and turned over 500 million Euros. In fact Valencia, where Langley campaigned Weapon of Choice, was not his first World Championship. Having acquired the 2008 generation Matador in September last year, the 2009 TP52 Worlds was Langley and his team’s first regatta in their new boat. Langley says he sailed dinghies occasionally during his childhood, but came to big boats during Antigua Sailing Week back in 1994 when he raced on the ancient Whitbread maxi Creighton’s Naturally. He was an irregular participant in regattas following this in chartered boats until 2005 when he bit the bullet and acquired the Farr 45 Atomic. He has been competing in the UK Farr 45 fleet ever since. “2006 was our first season,” says Langley. “I won IRC Zero in Round the Island. It was a light airs day and we had a bit of luck, but that was one of our great milestones.” Longley still actively campaigns the 45 and says that despite now owning a TP52 he is loath to shed the older boat because he enjoys racing

VISITORS